Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
ALICE PHARMA AS
AS
Active
Org 921176104
Annen forskning og annet utviklingsarbeid innen naturvitenskap og teknikk
·
NACE 72190
Est. 2018 · 7 years old
0 employees
Overvåg
Share
Norway
/
Companies
/
Annen forskning og annet utviklingsarbeid innen naturvitenskap og teknikk
/
ALICE PHARMA AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2018
0M
2019
EBITDA
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2018
0M
0%
2019
Income statement
NOK thousands
Item
2018
2019
Revenue
0
0
Staff expenses
−0
−0
EBITDA
−15
−0
Depreciation & amort.
−0
−0
EBIT
−15
−0
Net financials
0
−0
Profit before tax
−15
−0
Tax
−0
−0
Net profit
−15
−0
Balance sheet
NOK thousands
Item
2018
2019
Total assets
30
30
Equity
15
15
Long-term debt
0
0
Short-term debt
15
15
Total debt
15
15
Financial ratios
5-year trend
EBITDA-margin
-16700.0%
This company
15.8%
Market median
-105796% vs market
2018
2019
Soliditetsgrad
51.0%
This company
38.2%
Market median
+34% vs market
2018
2019
Egenkapitalforrentning
-1.1%
This company
18.4%
Market median
-106% vs market
2018
2019
Nettoresultatgrad
-16900.0%
This company
8.1%
Market median
-208742% vs market
2018
2019
Aktivomsætning
0.00×
This company
1.12×
Market median
-100% vs market
2018
2019
Gæld/egenkapital
0.96×
This company
0.62×
Market median
+55% vs market
2018
2019
Annual reports & filings
Annual report 2019
Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
View
PDF
Annual report 2018
Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
View
PDF
More on ALICE PHARMA AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
